Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-29

Clinical Trial Update: Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia [Phase 4]

View source ↗

Summary

Phase 4 real-world study evaluating Symbicort (budesonide/formoterol) as maintenance and reliever therapy in asthma patients in Malaysia; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2009-12-29